日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of stable liquid glucagon formulations for use in artificial pancreas

开发用于人工胰腺的稳定液态胰高血糖素制剂

Pohl, Roderike; Li, Ming; Krasner, Alan; De Souza, Errol

Ultra-rapid absorption of recombinant human insulin induced by zinc chelation and surface charge masking

锌螯合和表面电荷掩蔽诱导重组人胰岛素的超快速吸收

Pohl, Roderike; Hauser, Robert; Li, Ming; De Souza, Errol; Feldstein, Robert; Seibert, Richard; Ozhan, Koray; Kashyap, Nandini; Steiner, Solomon

A review of a family of ultra-rapid-acting insulins: formulation development

超速效胰岛素系列药物的综述:制剂研发

Krasner, Alan; Pohl, Roderike; Simms, Patrick; Pichotta, Philip; Hauser, Robert; De Souza, Errol

Stabilized glucagon formulation for bihormonal pump use

用于双激素泵的稳定型胰高血糖素制剂

Steiner, Solomon S; Li, Ming; Hauser, Robert; Pohl, Roderike

Intra-individual variability of the metabolic effect of a novel rapid-acting insulin (VIAject) in comparison to regular human insulin

新型速效胰岛素(VIAject)与常规人胰岛素相比,其代谢效应的个体内部差异

Hompesch, Marcus; McManus, Laura; Pohl, Roderike; Simms, Patrick; Pfützner, Andreas; Bülow, Elena; Flacke, Frank; Heinemann, Lutz; Steiner, Solomon S